Jefferies sets $50 price target on Latigo Biotherapeutics
Jefferies announced a $50.00/share price target for Latigo Biotherapeutics.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.